-
1
-
-
0000927260
-
Ein Syndrome von Adipositas, Kleinwuchs, Kriptorchismus und Oligofrenie nach myotonieartigem Zustandim Neugeborenenalter
-
PRADER A, LABHART A, WILLI H. Ein Syndrome von Adipositas, Kleinwuchs, Kriptorchismus und Oligofrenie nach myotonieartigem Zustandim Neugeborenenalter. Schweiz Med Wochenschr 1956; 86: 1260-1.
-
(1956)
Schweiz Med Wochenschr
, vol.86
, pp. 1260-1261
-
-
Prader, A.1
Labhart, A.2
Willi, H.3
-
2
-
-
0027476242
-
Prader-Willi syndrome: Consensus diagnostic criteria
-
HOLM VA, CASSIDY SB, BUTLER MG, HANCHETT JM, GREENSWAG LR, WHITMAN DY ET AL. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993; 91: 398-402.
-
(1993)
Pediatrics
, vol.91
, pp. 398-402
-
-
Holm, V.A.1
Cassidy, S.B.2
Butler, M.G.3
Hanchett, J.M.4
Greenswag, L.R.5
Whitman, D.Y.6
-
3
-
-
0029867499
-
Diagnostic testing for Prader-Willi and Angelman syndromes
-
AMERICAN SOCIETY OF HUMAN GENETICS/AMERICAN COLLEGE OF MEDICAL GENETICS TESTS AND TECHNOLOGY TRANSFER COMMITTEE. Diagnostic testing for Prader-Willi and Angelman syndromes. Am J Hum Genet 1996; 58: 1085-8.
-
(1996)
Am J Hum Genet
, vol.58
, pp. 1085-1088
-
-
-
4
-
-
0001593969
-
Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency
-
THACKER MJ, HAINLINE B, ST DENNISE-FEEZLE L, JOHNSON NB, PESCOVITZ OH. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency. Horm Res 1998; 49: 216-20.
-
(1998)
Horm Res
, vol.49
, pp. 216-220
-
-
Thacker, M.J.1
Hainline, B.2
St. Dennise-Feezle, L.3
Johnson, N.B.4
Pescovitz, O.H.5
-
5
-
-
0031933868
-
Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably
-
LINDGREN AC, HAGENÄS L, MÜLLER J, BLICHFELDT S, ROSENBORG M, BRISMAR T ET AL. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr 1998; 87: 28-31.
-
(1998)
Acta Paediatr
, vol.87
, pp. 28-31
-
-
Lindgren, A.C.1
Hagenäs, L.2
Müller, J.3
Blichfeldt, S.4
Rosenborg, M.5
Brismar, T.6
-
6
-
-
0033900036
-
Effects of growth hormone treatment in children with Prader-Willi syndrome
-
LEE PDK. Effects of growth hormone treatment in children with Prader-Willi syndrome. Growth Horm IGF Res 2000; Suppl B: S75-S79.
-
(2000)
Growth Horm IGF Res
, vol.SUPPL B
-
-
Lee, P.D.K.1
-
7
-
-
0042053458
-
-
Last update June 26, Disponible en URL
-
CASSIDY SB, SCHWARTZ S. Prader-Willi syndrome. Last update June 26, 2000. Disponible en URL http://www.geneclinics.com/profiles/pws/detail s.htlm
-
(2000)
Prader-Willi Syndrome
-
-
Cassidy, S.B.1
Schwartz, S.2
-
8
-
-
0034234891
-
Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups
-
LINGREN AC, BARKELING B, HAGG A, RITZÉN EM, MARCUS C, ROSSNER S. Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr 2000; 137: 50-5.
-
(2000)
J Pediatr
, vol.137
, pp. 50-55
-
-
Lingren, A.C.1
Barkeling, B.2
Hagg, A.3
Ritzén, E.M.4
Marcus, C.5
Rossner, S.6
-
9
-
-
0033966287
-
Leptin concentration in Prader-Willi syndrome before and after growth hormone replacement
-
Oxf
-
MYERS SE, DAVIS A, WHITMAN BY, SANTIAGO JV, LANDT M. Leptin concentration in Prader-Willi syndrome before and after growth hormone replacement. Clin Endocrinol (Oxf) 2000; 52: 101-5.
-
(2000)
Clin Endocrinol
, vol.52
, pp. 101-105
-
-
Myers, S.E.1
Davis, A.2
Whitman, B.Y.3
Santiago, J.V.4
Landt, M.5
-
10
-
-
0034129461
-
Failure of biliopancreatic diversion in Prader-Willi syndrome
-
GRUGNI G, GUZZALONI G, MORABITO F. Failure of biliopancreatic diversion in Prader-Willi syndrome. Obes Surg 2000; 10: 179-81.
-
(2000)
Obes Surg
, vol.10
, pp. 179-181
-
-
Grugni, G.1
Guzzaloni, G.2
Morabito, F.3
-
11
-
-
0025997680
-
Standards for selected anthropometric measurements in Prader-Willi syndrome
-
BUTLER MG, MEANY FG. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 1991; 88: 853-60.
-
(1991)
Pediatrics
, vol.88
, pp. 853-860
-
-
Butler, M.G.1
Meany, F.G.2
-
12
-
-
0031765833
-
Low insulin, IGF-1 and IGFBP3 levels in children with Prader-Labhart-Willi syndrome
-
EIHOLZER U, STUTZ K, WEINMANN C, TORRESANI T, MOLINARI L, PRADER A. Low insulin, IGF-1 and IGFBP3 levels in children with Prader-Labhart-Willi syndrome. Eur J Pediatr 1998; 157: 890-3.
-
(1998)
Eur J Pediatr
, vol.157
, pp. 890-893
-
-
Eiholzer, U.1
Stutz, K.2
Weinmann, C.3
Torresani, T.4
Molinari, L.5
Prader, A.6
-
13
-
-
0033460213
-
Five years of growth hormone treatment in children with Prader-Willi syndrome
-
LINDGREN AC, RITZÉN EM. Five years of growth hormone treatment in children with Prader-Willi syndrome. Acta Paediatr 1999; Suppl 433: 109-11.
-
(1999)
Acta Paediatr
, vol.433
, Issue.SUPPL.
, pp. 109-111
-
-
Lindgren, A.C.1
Ritzén, E.M.2
-
14
-
-
0034234356
-
Sustained benefit after two years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome
-
MYERS SE, CARREL AL, WHITMAN BY, ALLEN DB. Sustained benefit after two years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 2000; 137: 42-9.
-
(2000)
J Pediatr
, vol.137
, pp. 42-49
-
-
Myers, S.E.1
Carrel, A.L.2
Whitman, B.Y.3
Allen, D.B.4
-
15
-
-
0031984102
-
Total body bone mineral measurement in children with Prader-Willi syndrome: The influence of the skull's bone mineral content per area (BMA) and of height
-
BRISMAR TB, LINDGREN AC, RINGERTZ H, ROSENBORG M, RITZEN EM. Total body bone mineral measurement in children with Prader-Willi syndrome: the influence of the skull's bone mineral content per area (BMA) and of height. Pediatr Radiol 1998; 28: 38-42.
-
(1998)
Pediatr Radiol
, vol.28
, pp. 38-42
-
-
Brismar, T.B.1
Lindgren, A.C.2
Ringertz, H.3
Rosenborg, M.4
Ritzen, E.M.5
-
16
-
-
0032871118
-
Growth hormone treatment increases CO(2) response, ventilation, and central inspiratory drive in children with Prader-Willi syndrome
-
LINDGREN AC, HELLSTRÖM LG, RITZEN ME, MILERAD J. Growth hormone treatment increases CO(2) response, ventilation, and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr 1999; 158: 936-40.
-
(1999)
Eur J Pediatr
, vol.158
, pp. 936-940
-
-
Lindgren, A.C.1
Hellström, L.G.2
Ritzen, M.E.3
Milerad, J.4
-
17
-
-
0001340221
-
Adverse events during growth hormone treatment: 5 years' experience in the Kabi international growth study
-
Ranke M, Gunnarson R: Mannheim, J & J Verlag
-
WILTON P. Adverse events during growth hormone treatment: 5 years' experience in the Kabi international growth study. En Ranke M, Gunnarson R: Progress in growth hormone therapy -5 years of KIGS. Mannheim, J & J Verlag 1994 pp 291-307.
-
(1994)
Progress in Growth Hormone Therapy -5 Years of KIGS
, pp. 291-307
-
-
Wilton, P.1
-
18
-
-
0033874318
-
Growth hormone therapy for Prader-Willi and Down syndromes: A post modern medical dilemma
-
LANTOS JD. Growth hormone therapy for Prader-Willi and Down syndromes: a post modern medical dilemma. Growth Horm IGF Res 2000; Suppl B: S93-S94.
-
(2000)
Growth Horm IGF Res
, vol.SUPPL B
-
-
Lantos, J.D.1
-
19
-
-
0035318985
-
Diagnóstico molecular de los síndromes de Prader-Willi y de Angelman: Análisis de metilación, citogenética y FISH
-
SANTA MARÍA L, CUROTTO B, CORTÉS F, ALLIENDE MA. Diagnóstico molecular de los síndromes de Prader-Willi y de Angelman: análisis de metilación, citogenética y FISH. Rev Méd Chile 2001; 129: 367-74.
-
(2001)
Rev Méd Chile
, vol.129
, pp. 367-374
-
-
Santa María, L.1
Curotto, B.2
Cortés, F.3
Alliende, M.A.4
|